<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Physiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id><journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id><journal-title-group><journal-title>Frontiers in Physiology</journal-title></journal-title-group><issn pub-type="epub">1664-042X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29311997</article-id><article-id pub-id-type="pmc">5742195</article-id><article-id pub-id-type="doi">10.3389/fphys.2017.01086</article-id><article-categories><subj-group subj-group-type="heading"><subject>Physiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Superior Effects of High-Intensity Interval Training vs. Moderate Continuous Training on Arterial Stiffness in Episodic Migraine: A Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hanssen</surname><given-names>Henner</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><xref ref-type="author-notes" rid="fn003"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/483501/overview"/></contrib><contrib contrib-type="author"><name><surname>Minghetti</surname><given-names>Alice</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn003"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Magon</surname><given-names>Stefano</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/167609/overview"/></contrib><contrib contrib-type="author"><name><surname>Rossmeissl</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Papadopoulou</surname><given-names>Athina</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Klenk</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schmidt-Trucks&#x000e4;ss</surname><given-names>Arno</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/405745/overview"/></contrib><contrib contrib-type="author"><name><surname>Faude</surname><given-names>Oliver</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/359473/overview"/></contrib><contrib contrib-type="author"><name><surname>Zahner</surname><given-names>Lukas</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sprenger</surname><given-names>Till</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Donath</surname><given-names>Lars</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/361062/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Sport, Exercise and Health, University of Basel</institution>, <addr-line>Basel</addr-line>, <country>Switzerland</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Neurology, University Hospital Basel and University of Basel</institution>, <addr-line>Basel</addr-line>, <country>Switzerland</country></aff><aff id="aff3"><sup>3</sup><institution>Medical Image Analysis Center, University Hospital Basel</institution>, <addr-line>Basel</addr-line>, <country>Switzerland</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Neurology, DKD HELIOS Klinik Wiesbaden</institution>, <addr-line>Wiesbaden</addr-line>, <country>Germany</country></aff><aff id="aff5"><sup>5</sup><institution>Department of Intervention Research in Exercise Training, Institute of Exercise Training and Computer Science in Sport, German Sport University Cologne</institution>, <addr-line>K&#x000f6;ln</addr-line>, <country>Germany</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Jun Sugawara, National Institute of Advanced Industrial Science and Technology, Japan</p></fn><fn fn-type="edited-by"><p>Reviewed by: Takanobu Okamoto, Nippon Sport Science University, Japan; Masato Nishiwaki, Osaka Institute of Technology, Japan</p></fn><corresp id="fn001">*Correspondence: Henner Hanssen <email xlink:type="simple">henner.hanssen@unibas.ch</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Exercise Physiology, a section of the journal Frontiers in Physiology</p></fn><fn fn-type="other" id="fn003"><p>&#x02020;These authors have contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>19</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>1086</elocation-id><history><date date-type="received"><day>10</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Hanssen, Minghetti, Magon, Rossmeissl, Papadopoulou, Klenk, Schmidt-Trucks&#x000e4;ss, Faude, Zahner, Sprenger and Donath.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Hanssen, Minghetti, Magon, Rossmeissl, Papadopoulou, Klenk, Schmidt-Trucks&#x000e4;ss, Faude, Zahner, Sprenger and Donath</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><bold>Background:</bold> Migraine is associated with increased cardiovascular risk and vascular dysfunction. Since aerobic exercise can reduce cardiovascular risk, the present randomized controlled trail aimed at investigating the effects of high-intensity interval training (HIT) vs. moderate continuous exercise training (MCT) on arterial stiffness in migraine patients.</p><p><bold>Methods:</bold> Forty-eight episodic migraineurs were initially enrolled in the study. 37 patients [female: 30; age: 37 (<italic>SD</italic>: 10); BMI: 23.1 (5.2); Migraine days per month: 3.7 (2.5)] completed the intervention. Central blood pressure, pulse wave reflection, and aortic pulse wave velocity (PWV) were obtained by an oscillometric monitor. Incremental treadmill exercise testing yielded maximal and submaximal fitness parameters. Participants were randomly assigned to either HIT, MCT, or a control group (CON). The intervention groups trained twice a week over a 12-week intervention period.</p><p><bold>Results:</bold> After adjustment for between-group baseline differences, a moderate meaningful overall reduction of the augmentation index at 75 min<sup>&#x02212;1</sup> heart rate (AIx@75) was observed [partial eta squared (<inline-formula><mml:math id="M1"><mml:msubsup><mml:mrow><mml:mo>&#x003b7;</mml:mo></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula>) = 0.16; <italic>p</italic> = 0.06]. With 91% likely beneficial effects, HIT was more effective in reducing AIx@75 than MCT [HIT: pre 22.0 (9.7), post 14.9 (13.0), standardized mean difference (SMD) = 0.62; MCT: pre 16.6 (8.5), post 21.3 (10.4), SMD &#x02212;0.49]. HIT induced a relevant reduction in central systolic blood pressure [cSBP: pre 118 (23) mmHg, post 110 (16) mmHg, SMD = 0.42] with a 59% possibly beneficial effect compared to CON, while MCT showed larger effects in lowering central diastolic blood pressure [pre 78 (7) mmHg, post 74 (7) mmHg, SMD = 0.61], presenting 60% possibly beneficial effects compared to CON. Central aortic PWV showed no changes in any of the three groups. Migraine days were reduced more successfully by HIT than MCT (HIT: SMD = 1.05; MCT: SMD = 0.43).</p><p><bold>Conclusion:</bold> HIT but not MCT reduces AIx@75 as a measure of pulse wave reflection and indirect marker of systemic arterial stiffness. Both exercise modalities beneficially affect central blood pressure. HIT proved to be an effective complementary treatment option to reduce vascular dysfunction and blood pressure in migraineurs.</p></abstract><kwd-group><kwd>migraine</kwd><kwd>exercise</kwd><kwd>high intensity interval training</kwd><kwd>arterial stiffness</kwd><kwd>cardiovascular risk</kwd><kwd>randomized controlled trial</kwd></kwd-group><counts><fig-count count="2"/><table-count count="3"/><equation-count count="0"/><ref-count count="51"/><page-count count="10"/><word-count count="6697"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Migraine is considered a debilitating neurological disease which recurs in the form of severe headache attacks accompanied with nausea, vomiting, phonophobia, and photophobia (Jim&#x000e9;nez Caballero and Mu&#x000f1;oz Escudero, <xref rid="B24" ref-type="bibr">2013</xref>). Despite high prevalence rates (Stovner and Andree, <xref rid="B43" ref-type="bibr">2010</xref>), the complex pathogenetic mechanisms involved in migraine remain to be elucidated (Jim&#x000e9;nez Caballero and Mu&#x000f1;oz Escudero, <xref rid="B24" ref-type="bibr">2013</xref>). Various studies have been able to link migraine to adverse vascular risk profiles (Sacco et al., <xref rid="B37" ref-type="bibr">2012</xref>, <xref rid="B36" ref-type="bibr">2015</xref>). Migraine is associated with an increased risk of cardiovascular disease (CVD) such as myocardial infarction and stroke (Kurth et al., <xref rid="B26" ref-type="bibr">2008</xref>; Sch&#x000fc;rks et al., <xref rid="B40" ref-type="bibr">2009</xref>, <xref rid="B41" ref-type="bibr">2011</xref>; Spector et al., <xref rid="B42" ref-type="bibr">2010</xref>). A recent study revealed that there are about 2.6 million individuals in the U.S. suffering from episodic migraine with one or more cardiovascular events or conditions (Buse et al., <xref rid="B10" ref-type="bibr">2017</xref>). Migraineurs have independently been associated with increased aortic stiffness and enhanced peripheral wave reflection (Schillaci et al., <xref rid="B39" ref-type="bibr">2010</xref>), endothelial dysfunction (Jim&#x000e9;nez Caballero and Mu&#x000f1;oz Escudero, <xref rid="B24" ref-type="bibr">2013</xref>) as well as increased hypercoagulability and inflammation (Kurth et al., <xref rid="B26" ref-type="bibr">2008</xref>). This evidence suggests that functional properties of large arteries are altered in migraine patients (Liman et al., <xref rid="B29" ref-type="bibr">2012</xref>), leading to an overall increase in cardiovascular risk (Liew et al., <xref rid="B28" ref-type="bibr">2006</xref>; Rose et al., <xref rid="B35" ref-type="bibr">2007</xref>; Kurth et al., <xref rid="B26" ref-type="bibr">2008</xref>, <xref rid="B27" ref-type="bibr">2016</xref>; Buse et al., <xref rid="B10" ref-type="bibr">2017</xref>).</p><p>Arterial stiffness is an established independent predictor of cardiovascular events and stroke in healthy patients (Mitchell et al., <xref rid="B31" ref-type="bibr">2010</xref>). The augmentation index (AIx) serves as an established systemic haemodynamic marker of pulse wave reflection and is closely related to the development of atherosclerosis and incidence cardiovascular events (Vlachopoulos et al., <xref rid="B46" ref-type="bibr">2010a</xref>). An increased AIx displays a greater contribution of the reflected wave to the central blood pressure, indicating increased arterial stiffness and cardiac afterload as well as an unfavorably altered central blood pressure. As the AIx is dependent on heart rate (HR) (Wilkinson et al., <xref rid="B50" ref-type="bibr">2000</xref>), the corrected augmentation index calculated for a set of heart rate of 75 beats per minute (AIx@75) is usually applied for a more valid comparison in resting state. Pulse wave velocity (PWV) is a direct measure of large artery stiffness and an independent predictor of CV morbidity and mortality (Hansen, <xref rid="B15" ref-type="bibr">2010</xref>; Vlachopoulos et al., <xref rid="B47" ref-type="bibr">2010b</xref>; Ben-Shlomo et al., <xref rid="B6" ref-type="bibr">2014</xref>).</p><p>Higher levels of physical activity and cardiorespiratory fitness reduce all-cause mortality and CVD (Rognmo et al., <xref rid="B34" ref-type="bibr">2004</xref>). Physical activity inversely correlates with an age-dependent increase of arterial stiffness (Kozakova et al., <xref rid="B25" ref-type="bibr">2007</xref>) and cardiorespiratory fitness and sports-related activity are inversely correlated with arterial stiffness in younger adults (Boreham et al., <xref rid="B8" ref-type="bibr">2004</xref>). More recently, higher levels of moderate-to-vigorous physical activity were independently associated with slower age-related progression of central arterial stiffness (Ahmadi-Abhari et al., <xref rid="B2" ref-type="bibr">2017</xref>). Furthermore, endurance exercise training has been shown to improve arterial stiffness in patients with coronary artery disease (Edwards et al., <xref rid="B13" ref-type="bibr">2004</xref>). Regular high-intensity interval training (HIT) has been shown to induce superior improvement in aerobic fitness, endothelial function, as well as other cardio-metabolic risk factors in comparison to moderate continuous exercise training (MCT) (Wisl&#x000f8;ff et al., <xref rid="B51" ref-type="bibr">2007</xref>; Tj&#x000f8;nna et al., <xref rid="B44" ref-type="bibr">2008</xref>). Higher exercise intensities applied in intermittent bouts of highly intense aerobic exercise seem to affect pulse wave reflection more beneficially than moderate continuous exercise (Hanssen et al., <xref rid="B17" ref-type="bibr">2015</xref>). To date, few studies have examined the effects of different exercise modalities in patients suffering from migraine (Hanssen et al., <xref rid="B16" ref-type="bibr">2017</xref>). This is the first study comparing the effects of different longer term exercise training modalities on arterial stiffness and attack frequency in migraineurs. We hypothesized that regular HIT is a more beneficial means compared to MCT for the reduction of central and peripheral arterial stiffness indices, blood pressure, and migraine attack frequency.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec><title>Study design and participants</title><p>The present study was designed as a three-armed randomized controlled trial with a primary endpoint set on the effect of exercise training on pulse wave reflection in patients with migraine. In order to determine a clinical baseline for disease severity, patients underwent a 4-week run-in period prior to the start of the intervention period. After the run-in period and pre-testing measurements, 48 patients were randomly assigned [minimization method (Pocock and Stone, <xref rid="B33" ref-type="bibr">2016</xref>), strata: age, gender, BMI, PA, migraine assessment according to MIDAS score, physical fitness determined by VO<sub>2</sub>max] to one of three groups: high intensity aerobic interval training group (HIT), moderate continuous aerobic training group (MCT), or control group (CON). Baseline parameters are depicted in Table <xref ref-type="table" rid="T1">1</xref>. The intervention groups MCT and HIT trained twice a week over the 12-week intervention period. CON were requested to maintain their habitual daily physical activity profile and received additional standard physical activity recommendations. During the 12 weeks, a total of 11 (23%) patients dropped out due to injury, lack of motivation or personal reasons (Figure <xref ref-type="fig" rid="F1">1</xref>). Before and after 12 weeks of training, pulse wave reflection, PWV, and cardiopulmonary exercise testing were assessed in pre- and post-testing procedures. During the entire training study, patients were asked to keep a migraine and physical activity diary documenting the frequency and side effects of the attacks as well as their physical activity profiles. The study was registered in the German clinical trial register (DRKS-ID: DRKS00008015) and has been approved by the regional ethics committee (Ethical approval number: 194/13). All subjects signed an informed written consent after receiving all relevant study information.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Baseline data of the participants for both intervention groups (HIT and MCT) and the control group (CON).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>HIT</bold><break/> (n = 13)</th><th valign="top" align="center" rowspan="1" colspan="1"><bold>MCT</bold><break/> (n = 12)</th><th valign="top" align="center" rowspan="1" colspan="1"><bold>CON</bold><break/> (n = 12)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender [m/f]</td><td valign="top" align="center" rowspan="1" colspan="1">3/10</td><td valign="top" align="center" rowspan="1" colspan="1">2/10</td><td valign="top" align="center" rowspan="1" colspan="1">2/10</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age [years]</td><td valign="top" align="center" rowspan="1" colspan="1">36.2 (10.7)</td><td valign="top" align="center" rowspan="1" colspan="1">36.5 (8.7)</td><td valign="top" align="center" rowspan="1" colspan="1">37.3 (11.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMI [kg&#x000b7;m<sup>&#x02212;2</sup>]</td><td valign="top" align="center" rowspan="1" colspan="1">22.4 (3.0)</td><td valign="top" align="center" rowspan="1" colspan="1">23.6 (9.7)</td><td valign="top" align="center" rowspan="1" colspan="1">23.4 (2.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Systolic BP [mmHg]</td><td valign="top" align="center" rowspan="1" colspan="1">118.1 (23.4)</td><td valign="top" align="center" rowspan="1" colspan="1">109.8 (9.1)</td><td valign="top" align="center" rowspan="1" colspan="1">113.7 (10.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diastolic BP [mmHg]</td><td valign="top" align="center" rowspan="1" colspan="1">78.7 (5.9)</td><td valign="top" align="center" rowspan="1" colspan="1">77.8 (6.8)</td><td valign="top" align="center" rowspan="1" colspan="1">78.3 (7.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FFKA_MET [MET/week]</td><td valign="top" align="center" rowspan="1" colspan="1">36.5 (50.8)</td><td valign="top" align="center" rowspan="1" colspan="1">38.9 (37.0)</td><td valign="top" align="center" rowspan="1" colspan="1">35.1 (20.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MIDAS [score]</td><td valign="top" align="center" rowspan="1" colspan="1">21.4 (13.4)</td><td valign="top" align="center" rowspan="1" colspan="1">24.0 (20.9)</td><td valign="top" align="center" rowspan="1" colspan="1">16.3 (8.9)</td></tr></tbody></table><table-wrap-foot><p><italic>Data are provided as means with standard deviations (SD). Gender is indicated as f, female; m, male; BMI, body mass index; BP, blood pressure; HR, resting heart rate; FFKA_MET, Freiburger Physical Activity Questionnaire expressed in metabolic equivalents per week; MIDAS, Migraine Disability Assessment Questionnaire expressed in MIDAS score</italic>.</p></table-wrap-foot></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>Flow-chart of the randomized controlled trial.</p></caption><graphic xlink:href="fphys-08-01086-g0001"/></fig><p>All examinations were performed at the University of Basel, Switzerland. Patients were recruited from the outpatient division of the Department of Neurology at the University Hospital Basel and via advertisements. Following the initial clinical screening, confirmation of the diagnosis was given by a neurologist. The neurological examinations were normal in all patients.</p></sec><sec><title>Inclusion and exclusion criteria</title><p>Inclusion criteria comprising the diagnosis of episodic migraine without aura were confirmed by an experienced neurologist according to the International Classification of Headache Disorders, third edition (ICHD-IIIb) (Headache Classification Committee of the International Headache Society, <xref rid="B18" ref-type="bibr">2013</xref>). Exclusion criteria were (a) current medical preventive therapy (patients were included if preventive medication was stopped at least 8 weeks prior to study participation), (b) other internal or neurological diseases, and (c) regular exercise experience within the last 6 months. The ability to participate in an intense exercise program was confirmed using the physical activity readiness questionnaire (PAR-Q) and the exercise test. Patients with CVD or acute or chronic inflammatory disease were not included in the study.</p></sec><sec><title>Testing procedures</title><sec><title>Arterial stiffness</title><p>Arterial stiffness parameters were obtained using an oscillometric Mobil-O-Graph&#x000ae; PWA Monitor device (I.E.M GmbH, Stolberg, Germany) with integrated ARCSolver&#x000ae; software. The blood pressure cuff was placed on the left upper arm while the patient was lying in a resting supine position. The measurements of arterial stiffness and central hemodynamics using the oscillometric method stand in good agreement with the conventional tonometric method (Wassertheurer et al., <xref rid="B49" ref-type="bibr">2010</xref>). The first of three measurements was performed after 5 min of resting period. The two following measurements were performed at 2-min intervals. From the measurements, central blood pressures, crude Aix, and AIx@75 as well as PWV were extracted. After data readout, every measurement was reviewed for erroneous values. The mean and standard deviation of three valid measurements were calculated.</p></sec><sec><title>Recording migraine days</title><p>Prior to training (4-week run-in period) and during the exercise intervention a standardized paper and pencil migraine diary was kept by all patients (Baos et al., <xref rid="B4" ref-type="bibr">2005</xref>). The last 4 weeks of the intervention period were considered as post value.</p></sec><sec><title>Maximal exercise testing</title><p>Exercise testing was conducted on a treadmill (HP Cosmos Pulsar, H/P/COSMOS Sports &#x00026; Medical, Germany) to determine the individual anaerobic lactate-threshold (LT), maximal heart rate (HR<sub>max</sub>), and VO<sub>2max</sub>. To obtain these data within one test, incremental protocols were combined with a ramp-like protocol (Meyer et al., <xref rid="B30" ref-type="bibr">2007</xref>). Patients started at 5 km/h, step duration lasted 3 min with an increment of 1 km/h and a capillary lactate withdrawal for each step. After 5 steps (9 km/h), a ramp-wise increase of 1.0 km/h per minute without lactate withdrawal was applied to assess VO<sub>2max</sub> (Scharhag-Rosenberger et al., <xref rid="B38" ref-type="bibr">2012</xref>). During exercise testing, breath-by-breath spirometric gas-exchange data (Metamax 3b, Cortex, Leipzig, Germany), heart rate (HR) (Polar Electro Oy, Kempele, Finland), and ratings of perceived exertion (RPE) (Borg, <xref rid="B9" ref-type="bibr">1998</xref>) were collected. The maximum of the three highest consecutive oxygen uptake and heart rate values were regarded as VO<sub>2max</sub> and HR<sub>max</sub>, while the individual anaerobic LT was determined according to Hagberg and Coyle (<xref rid="B14" ref-type="bibr">1983</xref>). For the analyses, the running speed at the LT in kilometer per hour (km/h) was used.</p></sec><sec><title>Exercise intervention</title><p>Both HIT and MCT were conducted individually under supervision of a sports scientists at the Department of Sports, Exercise and Health (DSBG) of the University of Basel, Switzerland, and consisted of an individual running program on a treadmill. A general warm-up of 400 m easy running followed by two skipping exercises and a cool-down period of 400 m and stretching exercises were included. MCT was performed by maintaining the calculated target heart rate of 70% (&#x000b1; 5 beats per minutes, bpm) of HR<sub>max</sub> for 45 min (Helgerud et al., <xref rid="B20" ref-type="bibr">2007</xref>). Exercising 45 min at this specific intensity results in similar energy expenditure as the chosen HIT program (Helgerud et al., <xref rid="B20" ref-type="bibr">2007</xref>). During HIT, the target intensity of 90 to 95% HR<sub>max</sub> (&#x000b1;5 bpm) was generally reached after 1 min. Each interval lasted 4 min, followed by an active rest period of 3 min at 70% of HR<sub>max</sub>. The 4-min intervals were repeated four times (Helgerud et al., <xref rid="B20" ref-type="bibr">2007</xref>). HR-monitors collected heart rate data of each training session. The total training distance was recorded for each session. In total, 24 training sessions were conducted. It was required to complete at least 20 training sessions (~80% attendance, &#x0201c;per protocol&#x0201d; analysis) during the 12-week training period. No adverse and serious adverse events were reported.</p></sec><sec><title>Statistics</title><p>Indices of central haemodynamics and arterial stiffness, migraine attack frequency, and maximal and submaximal fitness were given as means with standard deviations (<italic>SD</italic>).</p><p>Analyses of covariance (ANCOVA) were computed to adjust between-group effects for potential baseline differences (Vickers and Altman, <xref rid="B45" ref-type="bibr">2001</xref>). To estimate practical relevance of the ANCOVA between group effects, effect sizes (partial eta squared, <inline-formula><mml:math id="M2"><mml:msubsup><mml:mrow><mml:mo>&#x003b7;</mml:mo></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula>) were additionally calculated. According to Cohen (Cohen et al., <xref rid="B12" ref-type="bibr">2013</xref>), an <inline-formula><mml:math id="M3"><mml:msubsup><mml:mrow><mml:mo>&#x003b7;</mml:mo></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> &#x02265; 0.01 indicates a small, &#x02265;0.06 a medium and &#x02265;0.14 a large effect. Standardized mean differences (Cohen's d, trivial: SMD &#x0003c; 0.2, small: 0.2 &#x02264; SMD &#x0003c; 0.5, moderate: 0.5 &#x02264; SMD &#x0003c; 0.8, large SMD &#x02265; 0.8; Cohen, <xref rid="B11" ref-type="bibr">1992</xref>) were calculated for each pairwise comparison for each variable.</p><p>Additionally, the absolute and percentage differences as well as the standardized mean differences (Cohen's d) in the change scores between HIT, MCT, and CON from pre- to post-testing were also calculated together with 90% confidence intervals according to the magnitude-based inference approach (Batterham and Hopkins, <xref rid="B5" ref-type="bibr">2006</xref>): These calculations were adjusted for pre-test values as well. A practically worthwhile change was assumed when the difference score was at least 0.2 of the between-subject standard deviation (Hopkins et al., <xref rid="B22" ref-type="bibr">2009</xref>). The probability for an effect being practically worthwhile was calculated according to the magnitude-based inference approach using the following scale: 25&#x02013;75%, possibly; 75&#x02013;95%, likely; 95&#x02013;99.5%, very likely; &#x0003e;99.5%, most likely (Batterham and Hopkins, <xref rid="B5" ref-type="bibr">2006</xref>). The default probabilities for declaring an effect practically beneficial were &#x0003c;0.5% (most unlikely) for harm and &#x0003e;25% (possibly) for benefit (Hopkins et al., <xref rid="B22" ref-type="bibr">2009</xref>). All calculations were conducted using a published spreadsheet in Microsoft&#x000ae; excel (Hopkins, <xref rid="B21" ref-type="bibr">2007</xref>).</p></sec></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec><title>Arterial stiffness</title><p>Taking baseline values into account, ANCOVA revealed a large and relevant between group effect for AIx@75 (<italic>p</italic> = 0.06, <inline-formula><mml:math id="M5"><mml:msubsup><mml:mrow><mml:mo>&#x003b7;</mml:mo></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> = 0.16). Pairwise comparison of AIx@75 showed moderate effects in HIT [pre: 22.0 (9.7), post: 14.9 (13.0), SMD = 0.62] with a likelihood of a meaningful effect of 85% likely beneficial compared to CON and 91% likely beneficial compared to MCT (Tables <xref ref-type="table" rid="T2">2</xref>, <xref ref-type="table" rid="T3">3</xref>). Figure <xref ref-type="fig" rid="F2">2</xref> demonstrates the pairwise between group comparisons for AIx@75 change scores. Central systolic blood pressure (cSBP) was lowered in HIT [cSBP HIT: pre: 118.1 (23.4), post: 109.8 (15.7), SMD = 0.42] with a likelihood of a meaningful effect of 59% possibly beneficial compared to CON. Central diastolic blood pressure showed moderate effects in MCT [pre: 77.8 (6.8), post: 73.7 (6.6), SMD = 0.61] with a likelihood of a meaningful effect of 60% possibly beneficial compared to CON (Tables <xref ref-type="table" rid="T2">2</xref>, <xref ref-type="table" rid="T3">3</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Pre and post intervention results of all three groups for peripheral and central vessel parameters and arterial stiffness parameters.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1"><bold>Pre mean (<italic>SD</italic>)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Post mean (<italic>SD</italic>)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>SMD</bold></th><th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1"><bold>ANCOVA</bold></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>p</italic></bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><inline-formula><mml:math id="M4"><mml:msubsup><mml:mrow><mml:mo>&#x003b7;</mml:mo></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula></bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Migraine days [Days/Month]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">3.8 (3.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1.4 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1.05</td><td valign="top" align="center" rowspan="1" colspan="1">0.13</td><td valign="top" align="center" rowspan="1" colspan="1">0.13</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">4.2 (2.2)</td><td valign="top" align="center" rowspan="1" colspan="1">3.1 (2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.43</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">3.2 (2.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2.0 (1.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.59</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pSBP [mmHg]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">118.8 (8.1)</td><td valign="top" align="center" rowspan="1" colspan="1">115.6 (9.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.37</td><td valign="top" align="center" rowspan="1" colspan="1">0.57</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">117.7 (10.2)</td><td valign="top" align="center" rowspan="1" colspan="1">118.0 (13.3)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.03</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">121.8 (11.1)</td><td valign="top" align="center" rowspan="1" colspan="1">120.7 (10.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.10</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pDBP [mmHg]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">78.7 (5.9)</td><td valign="top" align="center" rowspan="1" colspan="1">76.8 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.28</td><td valign="top" align="center" rowspan="1" colspan="1">0.31</td><td valign="top" align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">76.8 (6.7)</td><td valign="top" align="center" rowspan="1" colspan="1">73.2 (6.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.55</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">78.3 (7.6)</td><td valign="top" align="center" rowspan="1" colspan="1">77.4 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pPP [mmHg]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">40.1 (4.6)</td><td valign="top" align="center" rowspan="1" colspan="1">38.4 (4.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.36</td><td valign="top" align="center" rowspan="1" colspan="1">0.31</td><td valign="top" align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">40.9 (7.3)</td><td valign="top" align="center" rowspan="1" colspan="1">40.3 (7.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">43.5 (6.2)</td><td valign="top" align="center" rowspan="1" colspan="1">43.4 (5.1)</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">cSBD [mmHg]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">118.1 (23.4)</td><td valign="top" align="center" rowspan="1" colspan="1">109.8 (15.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.42</td><td valign="top" align="center" rowspan="1" colspan="1">0.50</td><td valign="top" align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">109.8 (9.1)</td><td valign="top" align="center" rowspan="1" colspan="1">107.0 (8.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.33</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">113.7 (10.8)</td><td valign="top" align="center" rowspan="1" colspan="1">113.1 (11.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">cDBD [mmHg]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">79.1 (5.9)</td><td valign="top" align="center" rowspan="1" colspan="1">78.2 (11.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.10</td><td valign="top" align="center" rowspan="1" colspan="1">0.33</td><td valign="top" align="center" rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">77.8 (6.8)</td><td valign="top" align="center" rowspan="1" colspan="1">73.7 (6.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.61</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">79.1 (7.7)</td><td valign="top" align="center" rowspan="1" colspan="1">78.3 (7.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">cPP [mmHg]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">32.7 (5.6)</td><td valign="top" align="center" rowspan="1" colspan="1">31.7 (7.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.16</td><td valign="top" align="center" rowspan="1" colspan="1">0.42</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">32.0 (5.0)</td><td valign="top" align="center" rowspan="1" colspan="1">33.3 (4.4)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.28</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">34.6 (6.1)</td><td valign="top" align="center" rowspan="1" colspan="1">34.9 (6.2)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.05</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">AIx [%]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">28.2 (10.1)</td><td valign="top" align="center" rowspan="1" colspan="1">23.8 (13.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.37</td><td valign="top" align="center" rowspan="1" colspan="1">0.13</td><td valign="top" align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">21.9 (8.7)</td><td valign="top" align="center" rowspan="1" colspan="1">28.8 (12.7)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.63</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">23.6 (16.9)</td><td valign="top" align="center" rowspan="1" colspan="1">24.9 (13.4)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.09</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">AIx@75 [%]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">22.0 (9.7)</td><td valign="top" align="center" rowspan="1" colspan="1">14.9 (13.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.62</td><td valign="top" align="center" rowspan="1" colspan="1">0.06</td><td valign="top" align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">16.6 (8.5)</td><td valign="top" align="center" rowspan="1" colspan="1">21.3 (10.4)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.49</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">17.9 (15.9)</td><td valign="top" align="center" rowspan="1" colspan="1">18.8 (12.5)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.06</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PWV [m/s]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">5.9 (1.0)</td><td valign="top" align="center" rowspan="1" colspan="1">5.9 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0.79</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">5.8 (0.9)</td><td valign="top" align="center" rowspan="1" colspan="1">5.7 (0.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">6.0 (1.1)</td><td valign="top" align="center" rowspan="1" colspan="1">6.0 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">VO<sub>2max</sub> [ml/min/kgBW]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">36.8 (5.2)</td><td valign="top" align="center" rowspan="1" colspan="1">41.3 (8.3)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.65</td><td valign="top" align="center" rowspan="1" colspan="1">0.13</td><td valign="top" align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">36.9 (5.1)</td><td valign="top" align="center" rowspan="1" colspan="1">38.3 (6.1)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.25</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">36.2 (6.3)</td><td valign="top" align="center" rowspan="1" colspan="1">36.3 (5.7)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.02</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IAT [km/h]</td><td valign="top" align="left" rowspan="1" colspan="1">HIT</td><td valign="top" align="center" rowspan="1" colspan="1">8.2 (0.8)</td><td valign="top" align="center" rowspan="1" colspan="1">8.7 (0.6)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.71</td><td valign="top" align="center" rowspan="1" colspan="1">0.08</td><td valign="top" align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MCT</td><td valign="top" align="center" rowspan="1" colspan="1">8.3 (1.0)</td><td valign="top" align="center" rowspan="1" colspan="1">8.4 (1.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.10</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CON</td><td valign="top" align="center" rowspan="1" colspan="1">8.5 (1.1)</td><td valign="top" align="center" rowspan="1" colspan="1">8.3 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><italic>All results depicted as mean and standard deviation (SD). pSBP, peripheral systolic blood pressure; pDBP, peripheral diastolic blood pressure; pPP, peripheral pulse pressure; cSBP, central systolic blood pressure; cDBP, central diastolic blood pressure; cPP, central pulse pressure; AIx, Augmentationindex; AIx@75, Augmentationindex corrected for 75 beats per minute; PWV, pulse wave velocity</italic>.</p></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Parallel Group Trials for HIT, MCT, and CON.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Maximal parameters</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Differences in means</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Standardized mean difference [90% CI]</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Probability for a practically worthwhile effect</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>pSBP [mmHg]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.0 [&#x02212;5.6; 1.6]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.19 [&#x02212;0.54; 0.15]</td><td valign="top" align="left" rowspan="1" colspan="1">51%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">3.5 [&#x02212;4.1; 11.1]</td><td valign="top" align="center" rowspan="1" colspan="1">0.30 [&#x02212;0.36; 0.97]</td><td valign="top" align="left" rowspan="1" colspan="1">11%; unlikely beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;3.3 [&#x02212;10.5; 4.0]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.34 [&#x02212;1.09; 0.42]</td><td valign="top" align="left" rowspan="1" colspan="1">64%; possibly beneficial</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>pDBP [mmHg]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.1 [&#x02212;5.0; 2.7]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.16 [&#x02212;0.71; 0.38]</td><td valign="top" align="left" rowspan="1" colspan="1">47%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.0 [&#x02212;5.9; 1.8]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.27 [&#x02212;0.77; 0.24]</td><td valign="top" align="left" rowspan="1" colspan="1">61%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">1.8 [&#x02212;0.9; 4.6]</td><td valign="top" align="center" rowspan="1" colspan="1">0.27 [&#x02212;0.14; 0.69]</td><td valign="top" align="left" rowspan="1" colspan="1">3%; very unlikely beneficial</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>pPP [mmHg]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.5 [&#x02212;4.4; 1.4]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.25 [&#x02212;0.73; 0.24]</td><td valign="top" align="left" rowspan="1" colspan="1">58%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.3 [&#x02212;3.8; 3.3]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.04 [&#x02212;0.53; 0.45]</td><td valign="top" align="left" rowspan="1" colspan="1">30%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.3 [&#x02212;4.6; 2.0]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.20 [&#x02212;0.72; 0.31]</td><td valign="top" align="left" rowspan="1" colspan="1">52%; possibly beneficial</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>cSBP [mmHg]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;4.7 [&#x02212;13.0; 3.5]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.24 [&#x02212;0.67; 0.18]</td><td valign="top" align="left" rowspan="1" colspan="1">59%; possibly</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.9 [&#x02212;6.5; 0.8]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.27 [&#x02212;0.61; 0.08]</td><td valign="top" align="left" rowspan="1" colspan="1">66%; possibly</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">0.0 [&#x02212;8.2; 8.2]</td><td valign="top" align="center" rowspan="1" colspan="1">0.00 [&#x02212;0.42; 0.42]</td><td valign="top" align="left" rowspan="1" colspan="1">22%; unlikely</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>cDBP [mmHg]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.3 [&#x02212;7.9; 3.4]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.32 [&#x02212;1.11; 0.47]</td><td valign="top" align="left" rowspan="1" colspan="1">61%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.0 [&#x02212;6.2; 2.1]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.26 [&#x02212;0.80; 0.28]</td><td valign="top" align="left" rowspan="1" colspan="1">60%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">3.8 [0.1; 7.6]</td><td valign="top" align="center" rowspan="1" colspan="1">0.57 [0.01; 1.14]</td><td valign="top" align="left" rowspan="1" colspan="1">2%; very unlikely</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>cPP [mmHg]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.3 [&#x02212;4.8; 2.2]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.21 [&#x02212;0.78; 0.36]</td><td valign="top" align="left" rowspan="1" colspan="1">53%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">1.9 [&#x02212;1.2; 5.1]</td><td valign="top" align="center" rowspan="1" colspan="1">0.33 [&#x02212;0.20; 0.85]</td><td valign="top" align="left" rowspan="1" colspan="1">5%; unlikely beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.1 [&#x02212;4.8; 0.7]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.37 [&#x02212;0.87; 0.13]</td><td valign="top" align="left" rowspan="1" colspan="1">74%; possibly beneficial</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>AIx [%]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;4.4 [&#x02212;10.6; 1.9]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.30 [&#x02212;0.72; 0.13]</td><td valign="top" align="left" rowspan="1" colspan="1">76%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">4.5 [&#x02212;3.1; 12.2]</td><td valign="top" align="center" rowspan="1" colspan="1">0.32 [&#x02212;0.22; 0.86]</td><td valign="top" align="left" rowspan="1" colspan="1">6%; unlikely beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;7.8 [&#x02212;16.6; 0.9]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.74 [&#x02212;1.58; 0.09]</td><td valign="top" align="left" rowspan="1" colspan="1">87%; likely beneficial</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>AIx@75 [%]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;6.3 [&#x02212;12.2; &#x02212;0.3]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.45 [&#x02212;0.88; &#x02212;0.02]</td><td valign="top" align="left" rowspan="1" colspan="1">85%; likely beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">3.0 [&#x02212;3.4; 9.4]</td><td valign="top" align="center" rowspan="1" colspan="1">0.23 [&#x02212;0.25; 0.70]</td><td valign="top" align="left" rowspan="1" colspan="1">7%; unlikely beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;8.0 [&#x02212;15.6; &#x02212;0.3]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.80 [&#x02212;1.56; &#x02212;0.03]</td><td valign="top" align="left" rowspan="1" colspan="1">91%; likely beneficial</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>PWV [m/s]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">0.0 [&#x02212;0.2; 0.2]</td><td valign="top" align="center" rowspan="1" colspan="1">0.04 [&#x02212;0.15; 0.23]</td><td valign="top" align="left" rowspan="1" colspan="1">2%; very unlikely beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">0.0 [&#x02212;0.2; 0.1]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.05 [&#x02212;0.16; 0.07]</td><td valign="top" align="left" rowspan="1" colspan="1">3%; very unlikely beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">0.1 [&#x02212;0.1; 0.3]</td><td valign="top" align="center" rowspan="1" colspan="1">0.07 [&#x02212;0.12; 0.27]</td><td valign="top" align="left" rowspan="1" colspan="1">2%; very unlikely beneficial</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>VO</bold><sub>2max</sub>
<bold>[ml/min/kgBW]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">4.7 [0.2; 9.3]</td><td valign="top" align="center" rowspan="1" colspan="1">0.79 [0.04; 1.54]</td><td valign="top" align="left" rowspan="1" colspan="1">91%; likely beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">1.5 [&#x02212;1.1; 4.1]</td><td valign="top" align="center" rowspan="1" colspan="1">0.25 [&#x02212;0.19; 0.69]</td><td valign="top" align="left" rowspan="1" colspan="1">60%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">3.1 [&#x02212;1.2; 7.4]</td><td valign="top" align="center" rowspan="1" colspan="1">0.57 [&#x02212;0.22; 1.37]</td><td valign="top" align="left" rowspan="1" colspan="1">80%; likely beneficial</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>IAT [km/h]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">1.1 [0.5; 1.6]</td><td valign="top" align="center" rowspan="1" colspan="1">1.07 [0.52; 1.61]</td><td valign="top" align="left" rowspan="1" colspan="1">99%; very likely beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">0.7 [0.0; 1.5]</td><td valign="top" align="center" rowspan="1" colspan="1">0.68 [0.00; 1.36]</td><td valign="top" align="left" rowspan="1" colspan="1">89%; likely beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">0.3 [&#x02212;0.1; 0.8]</td><td valign="top" align="center" rowspan="1" colspan="1">0.39 [&#x02212;0.12; 0.89]</td><td valign="top" align="left" rowspan="1" colspan="1">75%; likely beneficial</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>Migraine Days [Days/Month]</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.8 [&#x02212;1.7; 0.0]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.28 [&#x02212;0.58; 0.02]</td><td valign="top" align="left" rowspan="1" colspan="1">71%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCT vs. CON</td><td valign="top" align="center" rowspan="1" colspan="1">0.3 [&#x02212;0.9; 1.5]</td><td valign="top" align="center" rowspan="1" colspan="1">0.13 [&#x02212;0.34; 0.60]</td><td valign="top" align="left" rowspan="1" colspan="1">42%; possibly beneficial</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIT vs. MCT</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.5 [&#x02212;2.6; &#x02212;0.3]</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.54 [&#x02212;0.95; &#x02212;0.12]</td><td valign="top" align="left" rowspan="1" colspan="1">92%; likely beneficial</td></tr></tbody></table><table-wrap-foot><p><italic>Difference in means as well as standardized mean differences (90% confidence intervals) are given for peripheral and central haemodynamic parameters as well as for arterial stiffness. The probability for an effect being practically beneficial was calculated according to the magnitude-based inference method</italic>.</p></table-wrap-foot></table-wrap><fig id="F2" position="float"><label>Figure 2</label><caption><p>Mean change scores (%) for peripheral arterial stiffness (AIx@75) for pairwise between group comparison. Standardized mean differences are given as Cohen's d indicating moderate effects for HIT (0.5 &#x0003c; d &#x0003c; 0.7) compared to both groups. MCT vs. CON remains unchanged.</p></caption><graphic xlink:href="fphys-08-01086-g0002"/></fig><p>PWV showed no changes in any of the three groups (Tables <xref ref-type="table" rid="T2">2</xref>, <xref ref-type="table" rid="T3">3</xref>).</p></sec><sec><title>Migraine days</title><p>ANCOVA, again taking baseline values into account, revealed moderate and relevant between group effect for migraine days (<italic>p</italic> = 0.13, <inline-formula><mml:math id="M6"><mml:msubsup><mml:mrow><mml:mo>&#x003b7;</mml:mo></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> = 0.13). Pairwise comparison of migraine days showed very large effects in HIT [pre: 3.8 (3.0), post: 1.4 (1.2), SMD = 1.05] with a likelihood of a meaningful effect of 71% possibly beneficial compared to CON and 92% likely beneficial compared to MCT. MCT revealed a 42% possibly beneficial effect compared to CON. Migraine days are reported as number of migraine days per month (Tables <xref ref-type="table" rid="T2">2</xref>, <xref ref-type="table" rid="T3">3</xref>).</p></sec><sec><title>Maximal and submaximal fitness parameters</title><p>ANCOVA revealed a moderate but relevant between group effect for VO<sub>2max</sub> (<italic>p</italic> = 0.13, <inline-formula><mml:math id="M7"><mml:msubsup><mml:mrow><mml:mo>&#x003b7;</mml:mo></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> = 0.12) and IAT (<italic>p</italic> = 0.08, <inline-formula><mml:math id="M8"><mml:msubsup><mml:mrow><mml:mo>&#x003b7;</mml:mo></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> = 0.15). Pairwise comparison of VO<sub>2max</sub> showed moderate effects in favor of HIT [(ml/min/kg) pre: 36.8 (5.2), post: 41.3 (8.3), SMD = &#x02212;0.65] and small effects for MCT [(ml/min/kg) pre: 36.9 (5.1), post: 38.3 (6.1), SMD = &#x02212;0.25]. HIT showed a 91% likely beneficial effect while MCT revealed a 60% possibly beneficial effect over CON. Pairwise comparison of IAT revealed moderate effects in HIT [(km/h) pre: 8.2 (0.8), post: 8.7 (0.6), SMD = &#x02212;0.71].</p></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>The aim of the present randomized controlled trial was to investigate whether different aerobic exercise intensity modalities yield differential effects on central systolic and diastolic blood pressure, pulse wave reflection, and PWV in episodic migraineurs. To the best of our knowledge, no study to date has compared the effects of different exercise modalities and intensities on arterial stiffness and migraine. Our results show that HIT but not MCT was able to lower AIx@75 while both exercise programs were able to reduce migraine days and improve physical fitness. We could further elucidate that HIT is superior to MCT in improving AIx as an indirect marker of systemic arterial stiffness, which indicates cardiovascular risk reduction in migraineurs. The exercise-induced adaptations of arterial stiffness may be attributed in large part to an increased availability of nitric oxide (NO) and a consecutive improvement of endothelial function. Increases in shear stress during exercise induce NO production of the endothelium, which results in relaxation of vascular smooth muscle cells, arterial vasodilation, and a drop in vascular resistance (Alsop and Hauton, <xref rid="B3" ref-type="bibr">2016</xref>). It has been suggested that the regulation of vascular tone in response to endothelial sheer stress stimulus is impaired in migraineurs and NO is regarded as crucial factor in the process (Buse et al., <xref rid="B10" ref-type="bibr">2017</xref>). An increased nitrate-mediated response during development of migraine has been suggested, supporting the theory of overregulated NO sensitivity in migraineurs (Buse et al., <xref rid="B10" ref-type="bibr">2017</xref>). Our results indirectly suggest that the improvement of NO regulation is intensity-dependent, whereby higher intensities applied in intervals compel stronger vascular adaptations. These findings correspond to previous findings comparing acute effects of HIT and MCT on arterial stiffness, which showed that AIx@75 declined significantly over time after HIT but less after MCT (Hanssen et al., <xref rid="B17" ref-type="bibr">2015</xref>). HIT induces higher laminar shear stress compared to lower continuous exercise intensities and, therefore, HIT represents a stronger stimulus for shear stress-induced release of NO (Adams et al., <xref rid="B1" ref-type="bibr">2017</xref>). This may, in part, explain why HIT reduced AIx@75 as well as migraine days more efficiently than MCT. Regular exercise, and HIT in particular, has the potential to improve NO production and regulation in migraineurs and reduce migraine days. Further research is needed to clarify the postulated mechanistic link and its causality.</p><p>Interestingly, PWV showed no changes in any of the three groups even though HIT reduced central systolic blood pressure while MCT reduced central diastolic blood pressure. These results are in line with the few studies which have examined the effects of exercise on PWV (Heffernan et al., <xref rid="B19" ref-type="bibr">2007</xref>; Munir et al., <xref rid="B32" ref-type="bibr">2008</xref>). Central arteries seem to require longer intervention periods with regular stimulus than the conduit and more peripheral vessels in order to adapt to aerobic exercise stimuli (Hanssen et al., <xref rid="B17" ref-type="bibr">2015</xref>). As expected, CON underwent no changes in any arterial stiffness parameters.</p><p>Migraine attacks are accompanied by repeated spells of vascular inflammation and repeated attacks of migraine have been suggested to induce inflammatory changes of cranial arteries (Bolay et al., <xref rid="B7" ref-type="bibr">2002</xref>). These recurring inflammatory processes may predispose to vascular endothelial dysfunction (Schillaci et al., <xref rid="B39" ref-type="bibr">2010</xref>). In previous studies, HIT has been shown to be superior to MCT in reducing arterial stiffness over a 24 h period in normotensive patients (Hanssen et al., <xref rid="B17" ref-type="bibr">2015</xref>) as well as reducing cardio-metabolic risk in patients with CVD (Wisl&#x000f8;ff et al., <xref rid="B51" ref-type="bibr">2007</xref>). The improvement of AIx@75 following HIT in our study indicates the potential to reduce cardiovascular risk in migraineurs, as a decrease in AIx is associated with a decreased cardiac afterload and left ventricular burden long-term (Vlachopoulos et al., <xref rid="B48" ref-type="bibr">2012</xref>; Hanssen et al., <xref rid="B17" ref-type="bibr">2015</xref>). A 10% increase of AIx is associated with a 30% increased relative risk for cardiovascular events (Vlachopoulos et al., <xref rid="B47" ref-type="bibr">2010b</xref>). Therefore, HIT may prove to be an effective therapy for the reduction of migraine symptoms, improving vascular function and integrity as well as reducing cardiovascular risk. We would like to postulate that interval-like application of high intensities evoke patterns of wave reflection that improve vascular function more than continuous lower intensity applications. Increased NO bioavailability evoked by the HIT protocol is one of the most likely mechanisms that help explain these findings.</p><p>The study comprises some limitations that need to be mentioned. The sample size of the pilot study might be considered low. In our group analysis, we refrained from interpreting our data on the basis of mere conventional <italic>p</italic>-values to estimate relevant between-group effects, as <italic>p</italic>-values do not sufficiently allow for continuous estimation of relevant interventional effect sizes (Pocock and Stone, <xref rid="B33" ref-type="bibr">2016</xref>). Indeed, these would have failed to reach significance due to the relatively small sample size of this study. Although increased arterial stiffness and cardiovascular risk has been reported in migraine, the patients in our study did not have impaired baseline levels of AIx or PWV according to the current recommendations for normal values (Hansen, <xref rid="B15" ref-type="bibr">2010</xref>; Janner et al., <xref rid="B23" ref-type="bibr">2010</xref>). A selection bias may have occurred whereby healthier and physically fitter patients were motivated to participate in the exercise intervention trial. In addition, despite group allocation based on physical fitness and migraine days per month, notable baseline differences in migraine days as well as arterial stiffness parameters AIx and AIX@75 need to be addressed. These findings might further be caused by the dropouts. We applied fitness and the MIDAS (migraine disability assessment) questionnaire as strata for group allocation. Moreover, we included baseline values and age as covariates. Thus, our results are adjusted for potential baseline differences.</p></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>Regular aerobic exercise has beneficial effects on blood pressure, vascular function, and cardiovascular risk. Since HIT was more effective in reducing systemic arterial stiffness and migraine days than MCT, we postulate that the exercise effects in migraine patients depend on intensity and modality of the exercise therapy. HIT should be considered as a complementary treatment strategy for migraine treatment and prevention. It is all the more important since drug treatment of migraine is oftentimes addressed with precautions in the presence of cardiovascular comorbidities. Exercise therapy seems to have the potential to play a crucial role in future preventive strategies to combat migraine complaints and development of associated CVD.</p></sec><sec id="s6"><title>Author contributions</title><p>Study design: HH, TS, and LD; data collection: AM, SM, AR, AP, and CK; statistical analysis: AM and LD; manuscript preparation: HH, AM, TS, and LD; manuscript revision: OF, AS-T, and LZ.</p><sec><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>We cordially thank all participants for their confidence and compliance in taking part in our research. We wish to thank the Neurology Department of the University Hospital of Basel (Alain Thoeni, Elena Gross) for their collaboration and flexibility. Furthermore, we would like to thank the students who were involved in data acquisition and conduction of measurements as well as coordination with the patients and supervision of training sessions.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This study was funded by the Research Fund of the University of Basel.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>V.</given-names></name><name><surname>Reich</surname><given-names>B.</given-names></name><name><surname>Uhlemann</surname><given-names>M.</given-names></name><name><surname>Niebauer</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium</article-title>. <source>Am. J. Physiol. Heart Circ. Physiol</source>. <volume>313</volume>, <fpage>H72</fpage>&#x02013;<lpage>H88</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00470.2016</pub-id><pub-id pub-id-type="pmid">28476924</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi-Abhari</surname><given-names>S.</given-names></name><name><surname>Sabia</surname><given-names>S.</given-names></name><name><surname>Shipley</surname><given-names>M. J.</given-names></name><name><surname>Kivim&#x000e4;ki</surname><given-names>M.</given-names></name><name><surname>Singh-Manoux</surname><given-names>A.</given-names></name><name><surname>Tabak</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Physical activity, sedentary behavior, and long-term changes in aortic stiffness: the whitehall II study</article-title>. <source>J. Am. Heart Assoc.</source>
<volume>6</volume>:<fpage>e005974</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.117.005974</pub-id><pub-id pub-id-type="pmid">28784651</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsop</surname><given-names>P.</given-names></name><name><surname>Hauton</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Oral nitrate and citrulline decrease blood pressure and increase vascular conductance in young adults: a potential therapy for heart failure</article-title>. <source>Eur. J. Appl. Physiol.</source>
<volume>116</volume>, <fpage>1651</fpage>&#x02013;<lpage>1661</lpage>. <pub-id pub-id-type="doi">10.1007/s00421-016-3418-7</pub-id><pub-id pub-id-type="pmid">27333912</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baos</surname><given-names>V.</given-names></name><name><surname>Ester</surname><given-names>F.</given-names></name><name><surname>Castellanos</surname><given-names>A.</given-names></name><name><surname>Nocea</surname><given-names>G.</given-names></name><name><surname>Caloto</surname><given-names>M. T.</given-names></name><name><surname>Gerth</surname><given-names>W. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes</article-title>. <source>Int. J. Clin. Pract.</source>
<volume>59</volume>, <fpage>281</fpage>&#x02013;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-1241.2005.00469.x</pub-id><pub-id pub-id-type="pmid">15857323</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batterham</surname><given-names>A. M.</given-names></name><name><surname>Hopkins</surname><given-names>W. G.</given-names></name></person-group> (<year>2006</year>). <article-title>Making meaningful inferences about magnitudes</article-title>. <source>Int. J. Sports Physiol. Perform.</source>
<volume>1</volume>, <fpage>50</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1123/ijspp.1.1.50</pub-id><pub-id pub-id-type="pmid">19114737</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Shlomo</surname><given-names>Y.</given-names></name><name><surname>Spears</surname><given-names>M.</given-names></name><name><surname>Boustred</surname><given-names>C.</given-names></name><name><surname>May</surname><given-names>M.</given-names></name><name><surname>Anderson</surname><given-names>S. G.</given-names></name><name><surname>Benjamin</surname><given-names>E. J.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects</article-title>. <source>J. Am. Coll. Cardiol.</source>
<volume>63</volume>, <fpage>636</fpage>&#x02013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2013.09.063</pub-id><pub-id pub-id-type="pmid">24239664</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolay</surname><given-names>H.</given-names></name><name><surname>Reuter</surname><given-names>U.</given-names></name><name><surname>Dunn</surname><given-names>A. K.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Boas</surname><given-names>D. A.</given-names></name><name><surname>Moskowitz</surname><given-names>M. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model</article-title>. <source>Nat. Med.</source>
<volume>8</volume>, <fpage>136</fpage>&#x02013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1038/nm0202-136</pub-id><pub-id pub-id-type="pmid">11821897</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boreham</surname><given-names>C. A.</given-names></name><name><surname>Ferreira</surname><given-names>I.</given-names></name><name><surname>Twisk</surname><given-names>J. W.</given-names></name><name><surname>Gallagher</surname><given-names>A. M.</given-names></name><name><surname>Savage</surname><given-names>M. J.</given-names></name><name><surname>Murray</surname><given-names>L. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Cardiorespiratory fitness, physical activity, and arterial stiffness: the Northern Ireland young hearts project</article-title>. <source>Hypertension</source>
<volume>44</volume>, <fpage>721</fpage>&#x02013;<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.0000144293.40699.9a</pub-id><pub-id pub-id-type="pmid">15452034</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>G.</given-names></name></person-group> (<year>1998</year>). <source>Perceived Exertion and Pain Scales</source>. <publisher-loc>Champaign, IL</publisher-loc>: <publisher-name>Human Kinetics</publisher-name>.</mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buse</surname><given-names>D. C.</given-names></name><name><surname>Reed</surname><given-names>M. L.</given-names></name><name><surname>Fanning</surname><given-names>K. M.</given-names></name><name><surname>Kurth</surname><given-names>T.</given-names></name><name><surname>Lipton</surname><given-names>R. B.</given-names></name></person-group> (<year>2017</year>). <article-title>Cardiovascular events, conditions, and procedures among people with episodic migraine in the US Population: results from the American migraine prevalence and prevention (AMPP) study</article-title>. <source>Headache</source>
<volume>57</volume>, <fpage>31</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1111/head.12962</pub-id><pub-id pub-id-type="pmid">27861837</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J.</given-names></name></person-group> (<year>1992</year>). <article-title>A power primer</article-title>. <source>Psychol. Bull.</source>
<volume>112</volume>, <fpage>155</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1037/0033-2909.112.1.155</pub-id><pub-id pub-id-type="pmid">19565683</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J.</given-names></name><name><surname>Cohen</surname><given-names>P.</given-names></name><name><surname>West</surname><given-names>S. G.</given-names></name><name><surname>Aiken</surname><given-names>L. S.</given-names></name></person-group> (<year>2013</year>). <source>Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences</source>. <publisher-loc>Mahwah, NJ</publisher-loc>: <publisher-name>Routledge</publisher-name>.</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>D. G.</given-names></name><name><surname>Schofield</surname><given-names>R. S.</given-names></name><name><surname>Magyari</surname><given-names>P. M.</given-names></name><name><surname>Nichols</surname><given-names>W. W.</given-names></name><name><surname>Braith</surname><given-names>R. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Effect of exercise training on central aortic pressure wave reflection in coronary artery disease</article-title>. <source>Am. J. Hypertens.</source>
<volume>17</volume>, <fpage>540</fpage>&#x02013;<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjhyper.2003.12.001</pub-id><pub-id pub-id-type="pmid">15177529</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>J. M.</given-names></name><name><surname>Coyle</surname><given-names>E. F.</given-names></name></person-group> (<year>1983</year>). <article-title>Physiological determinants of endurance performance as studied in competitive racewalkers</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>15</volume>, <fpage>287</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1249/00005768-198315040-00006</pub-id><pub-id pub-id-type="pmid">6621317</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>T. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors:'establishing normal and reference values'</article-title>. <source>Eur. Heart J.</source>
<volume>31</volume>, <fpage>2338</fpage>&#x02013;<lpage>2350</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehq165</pub-id><pub-id pub-id-type="pmid">20530030</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanssen</surname><given-names>H.</given-names></name><name><surname>Minghetti</surname><given-names>A.</given-names></name><name><surname>Magon</surname><given-names>S.</given-names></name><name><surname>Rossmeissl</surname><given-names>A.</given-names></name><name><surname>Rasenack</surname><given-names>M.</given-names></name><name><surname>Papadopoulou</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial</article-title>. <source>Scand. J. Med. Sci. Sports.</source> [Epub ahead of print]. <pub-id pub-id-type="doi">10.1111/sms.13023</pub-id><pub-id pub-id-type="pmid">29161767</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanssen</surname><given-names>H.</given-names></name><name><surname>Nussbaumer</surname><given-names>M.</given-names></name><name><surname>Moor</surname><given-names>C.</given-names></name><name><surname>Cordes</surname><given-names>M.</given-names></name><name><surname>Schindler</surname><given-names>C.</given-names></name><name><surname>Schmidt-Trucks&#x000e4;ss</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Acute effects of interval versus continuous endurance training on pulse wave reflection in healthy young men</article-title>. <source>Atherosclerosis</source>
<volume>238</volume>, <fpage>399</fpage>&#x02013;<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2014.12.038</pub-id><pub-id pub-id-type="pmid">25558034</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Headache Classification Committee of the International Headache Society, IHS.</collab></person-group> (<year>2013</year>). <article-title>The international classification of headache disorders, 3rd edition (beta version)</article-title>. <source>Cephalalgia</source>
<volume>33</volume>, <fpage>629</fpage>&#x02013;<lpage>808</lpage>. <pub-id pub-id-type="doi">10.1177/0333102413485658</pub-id><pub-id pub-id-type="pmid">23771276</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heffernan</surname><given-names>K. S.</given-names></name><name><surname>Collier</surname><given-names>S. R.</given-names></name><name><surname>Kelly</surname><given-names>E. E.</given-names></name><name><surname>Jae</surname><given-names>S. Y.</given-names></name><name><surname>Fernhall</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>). <article-title>Arterial stiffness and baroreflex sensitivity following bouts of aerobic and resistance exercise</article-title>. <source>Int. J. Sports Med.</source>
<volume>28</volume>, <fpage>197</fpage>&#x02013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1055/s-2006-924290</pub-id><pub-id pub-id-type="pmid">17024636</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helgerud</surname><given-names>J.</given-names></name><name><surname>Hoydal</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name><name><surname>Karlsen</surname><given-names>T.</given-names></name><name><surname>Berg</surname><given-names>P.</given-names></name><name><surname>Bjerkaas</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Aerobic high-intensity intervals improve VO<sub>2</sub> max more than moderate training</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>39</volume>, <fpage>665</fpage>&#x02013;<lpage>671</lpage>. <pub-id pub-id-type="doi">10.1249/mss.0b013e3180304570</pub-id><pub-id pub-id-type="pmid">17414804</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>W. G.</given-names></name></person-group> (<year>2007</year>). <article-title>A spreadsheet for deriving a confidence interval, mechanistic inference and clinical inference from a P value</article-title>. <source>Sportscience</source>
<volume>11</volume>, <fpage>16</fpage>&#x02013;<lpage>21</lpage>.</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>W. G.</given-names></name><name><surname>Marshall</surname><given-names>S. W.</given-names></name><name><surname>Batterham</surname><given-names>A. M.</given-names></name><name><surname>Hanin</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Progressive statistics for studies in sports medicine and exercise science</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>41</volume>, <fpage>3</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0b013e31818cb278</pub-id><pub-id pub-id-type="pmid">19092709</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janner</surname><given-names>J. H.</given-names></name><name><surname>Godtfredsen</surname><given-names>N. S.</given-names></name><name><surname>Ladelund</surname><given-names>S.</given-names></name><name><surname>Vestbo</surname><given-names>J.</given-names></name><name><surname>Prescott</surname><given-names>E.</given-names></name></person-group> (<year>2010</year>). <article-title>Aortic augmentation index: reference values in a large unselected population by means of the SphygmoCor device</article-title>. <source>Am. J. Hypertens.</source>
<volume>23</volume>, <fpage>180</fpage>&#x02013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1038/ajh.2009.234</pub-id><pub-id pub-id-type="pmid">19959999</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez Caballero</surname><given-names>P. E.</given-names></name><name><surname>Mu&#x000f1;oz Escudero</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>Peripheral endothelial function and arterial stiffness in patients with chronic migraine: a case-control study</article-title>. <source>J. Headache Pain</source>
<volume>14</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.1186/1129-2377-14-8</pub-id><pub-id pub-id-type="pmid">23565915</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozakova</surname><given-names>M.</given-names></name><name><surname>Palombo</surname><given-names>C.</given-names></name><name><surname>Mhamdi</surname><given-names>L.</given-names></name><name><surname>Konrad</surname><given-names>T.</given-names></name><name><surname>Nilsson</surname><given-names>P.</given-names></name><name><surname>Staehr</surname><given-names>P. B.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Habitual physical activity and vascular aging in a young to middle-age population at low cardiovascular risk</article-title>. <source>Stroke</source>
<volume>38</volume>, <fpage>2549</fpage>&#x02013;<lpage>2555</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.107.484949</pub-id><pub-id pub-id-type="pmid">17656659</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurth</surname><given-names>T.</given-names></name><name><surname>Sch&#x000fc;rks</surname><given-names>M.</given-names></name><name><surname>Logroscino</surname><given-names>G.</given-names></name><name><surname>Gaziano</surname><given-names>J. M.</given-names></name><name><surname>Buring</surname><given-names>J. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Migraine, vascular risk, and cardiovascular events in women: prospective cohort study</article-title>. <source>BMJ</source>
<volume>337</volume>:<fpage>a636</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.a636</pub-id><pub-id pub-id-type="pmid">18687721</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurth</surname><given-names>T.</given-names></name><name><surname>Winter</surname><given-names>A. C.</given-names></name><name><surname>Eliassen</surname><given-names>A. H.</given-names></name><name><surname>Dushkes</surname><given-names>R.</given-names></name><name><surname>Mukamal</surname><given-names>K. J.</given-names></name><name><surname>Rimm</surname><given-names>E. B.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Migraine and risk of cardiovascular disease in women: prospective cohort study</article-title>. <source>BMJ</source>
<volume>353</volume>:<fpage>i2610</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.i2610</pub-id><pub-id pub-id-type="pmid">27247281</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liew</surname><given-names>G.</given-names></name><name><surname>Mitchell</surname><given-names>P.</given-names></name><name><surname>Wong</surname><given-names>T. Y.</given-names></name><name><surname>Wang</surname><given-names>J. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Retinal vascular caliber and migraine: the Blue Mountains eye study</article-title>. <source>Headache</source>
<volume>46</volume>, <fpage>997</fpage>&#x02013;<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00364.x</pub-id><pub-id pub-id-type="pmid">16732846</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liman</surname><given-names>T. G.</given-names></name><name><surname>Neeb</surname><given-names>L.</given-names></name><name><surname>Rosinski</surname><given-names>J.</given-names></name><name><surname>Wellwood</surname><given-names>I.</given-names></name><name><surname>Reuter</surname><given-names>U.</given-names></name><name><surname>Doehner</surname><given-names>W.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Peripheral endothelial function and arterial stiffness in women with migraine with aura: a case-control study</article-title>. <source>Cephalalgia</source>
<volume>32</volume>, <fpage>459</fpage>&#x02013;<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1177/0333102412444014</pub-id><pub-id pub-id-type="pmid">22523187</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>T.</given-names></name><name><surname>Auracher</surname><given-names>M.</given-names></name><name><surname>Heeg</surname><given-names>K.</given-names></name><name><surname>Urhausen</surname><given-names>A.</given-names></name><name><surname>Kindermann</surname><given-names>W.</given-names></name></person-group> (<year>2007</year>). <article-title>Effectiveness of low-intensity endurance training</article-title>. <source>Int. J. Sports Med.</source>
<volume>28</volume>, <fpage>33</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1055/s-2006-924037</pub-id><pub-id pub-id-type="pmid">17213964</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>G. F.</given-names></name><name><surname>Hwang</surname><given-names>S. J.</given-names></name><name><surname>Vasan</surname><given-names>R. S.</given-names></name><name><surname>Larson</surname><given-names>M. G.</given-names></name><name><surname>Pencina</surname><given-names>M. J.</given-names></name><name><surname>Hamburg</surname><given-names>N. M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Arterial stiffness and cardiovascular events: the Framingham heart study</article-title>. <source>Circulation</source>
<volume>121</volume>, <fpage>505</fpage>&#x02013;<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.886655</pub-id><pub-id pub-id-type="pmid">20083680</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munir</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>Guilcher</surname><given-names>A.</given-names></name><name><surname>Brett</surname><given-names>S.</given-names></name><name><surname>Redwood</surname><given-names>S.</given-names></name><name><surname>Marber</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Exercise reduces arterial pressure augmentation through vasodilation of muscular arteries in humans</article-title>. <source>Am. J. Physiol. Heart Circ. Physiol.</source>
<volume>294</volume>, <fpage>H1645</fpage>&#x02013;<lpage>H1650</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.01171.2007</pub-id><pub-id pub-id-type="pmid">18296568</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pocock</surname><given-names>S. J.</given-names></name><name><surname>Stone</surname><given-names>G. W.</given-names></name></person-group> (<year>2016</year>). <article-title>The primary outcome fails - what next?</article-title>
<source>N. Engl. J. Med.</source>
<volume>375</volume>, <fpage>861</fpage>&#x02013;<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1510064</pub-id><pub-id pub-id-type="pmid">27579636</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rognmo</surname><given-names>&#x000d8;.</given-names></name><name><surname>Hetland</surname><given-names>E.</given-names></name><name><surname>Helgerud</surname><given-names>J.</given-names></name><name><surname>Hoff</surname><given-names>J.</given-names></name><name><surname>Sl&#x000f8;rdahl</surname><given-names>S. A.</given-names></name></person-group> (<year>2004</year>). <article-title>High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease</article-title>. <source>Eur. J. Cardiovasc. Prev. Rehabil.</source>
<volume>11</volume>, <fpage>216</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1097/01.hjr.0000131677.96762.0c</pub-id><pub-id pub-id-type="pmid">15179103</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>K. M.</given-names></name><name><surname>Wong</surname><given-names>T. Y.</given-names></name><name><surname>Carson</surname><given-names>A. P.</given-names></name><name><surname>Couper</surname><given-names>D. J.</given-names></name><name><surname>Klein</surname><given-names>R.</given-names></name><name><surname>Sharrett</surname><given-names>A. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Migraine and retinal microvascular abnormalities: the atherosclerosis risk in communities study</article-title>. <source>Neurology</source>
<volume>68</volume>, <fpage>1694</fpage>&#x02013;<lpage>1700</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000261916.42871.05</pub-id><pub-id pub-id-type="pmid">17502551</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacco</surname><given-names>S.</given-names></name><name><surname>Ornello</surname><given-names>R.</given-names></name><name><surname>Ripa</surname><given-names>P.</given-names></name><name><surname>Tiseo</surname><given-names>C.</given-names></name><name><surname>Degan</surname><given-names>D.</given-names></name><name><surname>Pistoia</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies</article-title>. <source>Eur. J. Neurol.</source>
<volume>22</volume>, <fpage>1001</fpage>&#x02013;<lpage>1011</lpage>. <pub-id pub-id-type="doi">10.1111/ene.12701</pub-id><pub-id pub-id-type="pmid">25808832</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacco</surname><given-names>S.</given-names></name><name><surname>Ricci</surname><given-names>S.</given-names></name><name><surname>Carolei</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Migraine and vascular diseases: a review of the evidence and potential implications for management</article-title>. <source>Cephalalgia</source>
<volume>32</volume>, <fpage>785</fpage>&#x02013;<lpage>795</lpage>. <pub-id pub-id-type="doi">10.1177/0333102412451361</pub-id><pub-id pub-id-type="pmid">22711902</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharhag-Rosenberger</surname><given-names>F.</given-names></name><name><surname>Walitzek</surname><given-names>S.</given-names></name><name><surname>Kindermann</surname><given-names>W.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Differences in adaptations to 1 year of aerobic endurance training: individual patterns of nonresponse</article-title>. <source>Scand. J. Med. Sci. Sports</source>
<volume>22</volume>, <fpage>113</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0838.2010.01139.x</pub-id><pub-id pub-id-type="pmid">20561283</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schillaci</surname><given-names>G.</given-names></name><name><surname>Sarchielli</surname><given-names>P.</given-names></name><name><surname>Corbelli</surname><given-names>I.</given-names></name><name><surname>Pucci</surname><given-names>G.</given-names></name><name><surname>Settimi</surname><given-names>L.</given-names></name><name><surname>Mannarino</surname><given-names>M. R.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Aortic stiffness and pulse wave reflection in young subjects with migraine: a case-control study</article-title>. <source>Neurology</source>
<volume>75</volume>, <fpage>960</fpage>&#x02013;<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f25ecd</pub-id><pub-id pub-id-type="pmid">20837963</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000fc;rks</surname><given-names>M.</given-names></name><name><surname>Rist</surname><given-names>P. M.</given-names></name><name><surname>Bigal</surname><given-names>M. E.</given-names></name><name><surname>Buring</surname><given-names>J. E.</given-names></name><name><surname>Lipton</surname><given-names>R. B.</given-names></name><name><surname>Kurth</surname><given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>Migraine and cardiovascular disease: systematic review and meta-analysis</article-title>. <source>BMJ</source>
<volume>339</volume>:<fpage>b3914</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.b3914</pub-id><pub-id pub-id-type="pmid">19861375</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000fc;rks</surname><given-names>M.</given-names></name><name><surname>Rist</surname><given-names>P. M.</given-names></name><name><surname>Shapiro</surname><given-names>R. E.</given-names></name><name><surname>Kurth</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Migraine and mortality: a systematic review and meta-analysis</article-title>. <source>Cephalalgia</source>
<volume>31</volume>, <fpage>1301</fpage>&#x02013;<lpage>1314</lpage>. <pub-id pub-id-type="doi">10.1177/0333102411415879</pub-id><pub-id pub-id-type="pmid">21803936</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spector</surname><given-names>J. T.</given-names></name><name><surname>Kahn</surname><given-names>S. R.</given-names></name><name><surname>Jones</surname><given-names>M. R.</given-names></name><name><surname>Jayakumar</surname><given-names>M.</given-names></name><name><surname>Dalal</surname><given-names>D.</given-names></name><name><surname>Nazarian</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Migraine headache and ischemic stroke risk: an updated meta-analysis</article-title>. <source>Am. J. Med.</source>
<volume>123</volume>, <fpage>612</fpage>&#x02013;<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjmed.2009.12.021</pub-id><pub-id pub-id-type="pmid">20493462</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stovner</surname><given-names>L. J.</given-names></name><name><surname>Andree</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Prevalence of headache in Europe: a review for the eurolight project</article-title>. <source>J. Headache Pain</source>
<volume>11</volume>, <fpage>289</fpage>&#x02013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1007/s10194-010-0217-0</pub-id><pub-id pub-id-type="pmid">20473702</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tj&#x000f8;nna</surname><given-names>A. E.</given-names></name><name><surname>Lee</surname><given-names>S. J.</given-names></name><name><surname>Rognmo</surname><given-names>O.</given-names></name><name><surname>Stolen</surname><given-names>T. O.</given-names></name><name><surname>Bye</surname><given-names>A.</given-names></name><name><surname>Haram</surname><given-names>P. M.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study</article-title>. <source>Circulation</source>
<volume>118</volume>, <fpage>346</fpage>&#x02013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.772822</pub-id><pub-id pub-id-type="pmid">18606913</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vickers</surname><given-names>A. J.</given-names></name><name><surname>Altman</surname><given-names>D. G.</given-names></name></person-group> (<year>2001</year>). <article-title>Statistics notes: analysing controlled trials with baseline and follow up measurements</article-title>. <source>BMJ</source>
<volume>323</volume>, <fpage>1123</fpage>&#x02013;<lpage>1124</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.323.7321.1123</pub-id><pub-id pub-id-type="pmid">11701584</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachopoulos</surname><given-names>C.</given-names></name><name><surname>Aznaouridis</surname><given-names>K.</given-names></name><name><surname>O'Rourke</surname><given-names>M. F.</given-names></name><name><surname>Safar</surname><given-names>M. E.</given-names></name><name><surname>Baou</surname><given-names>K.</given-names></name><name><surname>Stefanadis</surname><given-names>C.</given-names></name></person-group> (<year>2010a</year>). <article-title>Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis</article-title>. <source>Eur. Heart J.</source>
<volume>31</volume>, <fpage>1865</fpage>&#x02013;<lpage>1871</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehq024</pub-id><pub-id pub-id-type="pmid">20197424</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachopoulos</surname><given-names>C.</given-names></name><name><surname>Aznaouridis</surname><given-names>K.</given-names></name><name><surname>Stefanadis</surname><given-names>C.</given-names></name></person-group> (<year>2010b</year>). <article-title>Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis</article-title>. <source>J. Am. Coll. Cardiol.</source>
<volume>55</volume>, <fpage>1318</fpage>&#x02013;<lpage>1327</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2009.10.061</pub-id><pub-id pub-id-type="pmid">20338492</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachopoulos</surname><given-names>C.</given-names></name><name><surname>Aznaouridis</surname><given-names>K.</given-names></name><name><surname>Terentes-Printzios</surname><given-names>D.</given-names></name><name><surname>Ioakeimidis</surname><given-names>N.</given-names></name><name><surname>Stefanadis</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis</article-title>. <source>Hypertension</source>
<volume>60</volume>, <fpage>556</fpage>&#x02013;<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.112.194779</pub-id><pub-id pub-id-type="pmid">22733468</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassertheurer</surname><given-names>S.</given-names></name><name><surname>Kropf</surname><given-names>J.</given-names></name><name><surname>Weber</surname><given-names>T.</given-names></name><name><surname>van der Giet</surname><given-names>M.</given-names></name><name><surname>Baulmann</surname><given-names>J.</given-names></name><name><surname>Ammer</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>A new oscillometric method for pulse wave analysis: comparison with a common tonometric method</article-title>. <source>J. Hum. Hypertens.</source>
<volume>24</volume>, <fpage>498</fpage>&#x02013;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1038/jhh.2010.27</pub-id><pub-id pub-id-type="pmid">20237499</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>I. B.</given-names></name><name><surname>MacCallum</surname><given-names>H.</given-names></name><name><surname>Flint</surname><given-names>L.</given-names></name><name><surname>Cockcroft</surname><given-names>J. R.</given-names></name><name><surname>Newby</surname><given-names>D. E.</given-names></name><name><surname>Webb</surname><given-names>D. J.</given-names></name></person-group> (<year>2000</year>). <article-title>The influence of heart rate on augmentation index and central arterial pressure in humans</article-title>. <source>J. Physiol.</source>
<volume>525</volume>(<issue>Pt 1</issue>), <fpage>263</fpage>&#x02013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.t01-1-00263.x</pub-id><pub-id pub-id-type="pmid">10811742</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisl&#x000f8;ff</surname><given-names>U.</given-names></name><name><surname>Stoylen</surname><given-names>A.</given-names></name><name><surname>Loennechen</surname><given-names>J. P.</given-names></name><name><surname>Bruvold</surname><given-names>M.</given-names></name><name><surname>Rognmo</surname><given-names>O.</given-names></name><name><surname>Haram</surname><given-names>P. M.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study</article-title>. <source>Circulation</source>
<volume>115</volume>, <fpage>3086</fpage>&#x02013;<lpage>3094</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.675041</pub-id><pub-id pub-id-type="pmid">17548726</pub-id></mixed-citation></ref></ref-list></back></article>